SCHEMBL8287939

SCHEMBL8287939

O=C(CCc1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1)Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.41
MAPT P10636 7/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.39
MAOB P27338 2/20 0.39
GAA P10253 2/20 0.38
TP53 P04637 5/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287945 0.91 S1PR1 (0.39) MAPTGAA
SCHEMBL8287917 0.89 GSK3B (0.36) MAPTALDH1A1HPGDNPC1GAA
SCHEMBL8287912 0.87 TSHR (0.38) MAPTALDH1A1GAATSHRSMN1; SMN2
SCHEMBL8287923 0.86 MAT2A (0.41)
SCHEMBL8287926 0.85 ALDH1A1 (0.42) MAPTALDH1A1HPGDHTTTP53
SCHEMBL8286162 0.85 GSK3B (0.37) MAPTALDH1A1HPGDGAA
SCHEMBL8287455 0.84 MAT2A (0.36) MAPTALDH1A1HPGDNPC1LMNA
SCHEMBL8287943 0.84 NPC1 (0.40) MAPTALDH1A1HPGDNPC1GAA
SCHEMBL8287483 0.83 ADORA3 (0.45) MAPTALDH1A1HPGDNPC1TP53
SCHEMBL8286150 0.83 GSK3B (0.39) ALDH1A1HPGDHTTGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed